x
Filter:
Filters applied
- Coronavirus (COVID-19) Collection
- Review ArticleRemove Review Article filter
- SeroprevalenceRemove Seroprevalence filter
- 2020 - 2022Remove 2020 - 2022 filter
Coronavirus (COVID-19) Collection
1 Results
- ReviewOpen Access
Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis
International Journal of Infectious DiseasesVol. 116p59–67Published online: December 27, 2021- Nuzrath Jahan
- Adarsha Brahma
- Muthusamy Santhosh Kumar
- Bhavani Shankara Bagepally
- Manickam Ponnaiah
- Tarun Bhatnagar
- and others
Cited in Scopus: 5COVID-19 caused by SARS-CoV-2 virus has spread rapidly across the world since December 2019. The pandemic has overwhelmed the health systems of developed and developing nations alike (Chowdhury & Jomo, 2020). Countries lacked the required ability to test, trace, treat, and isolate/quarantine the infected population. It is well established that true community burden would remain higher than the reported caseload owing to various reasons like asymptomatic infections, the differences in testing strategies by time and place, variable sensitivities of laboratory tests used for diagnosis, and other factors influencing the health-seeking behaviour of the population (M.